Cliff Asness's AZN Position Overview
Cliff Asness (via Aqr Capital Management LLC) currently holds 84,784 shares of AstraZeneca PLC (AZN) worth $6.5 M, representing 0.00% of the portfolio. First purchased in 2014-Q2, this long-term strategic position has been held for 46 quarters.
Based on 13F filings since 2013, Cliff Asness has maintained a long-term strategic position in AZN, representing a significant commitment to this investment thesis. Largest addition occurred in Q3 2025, adding 30,840 shares. Largest reduction occurred in Q3 2023, reducing 2.37 M shares.
Analysis based on 13F filings available since 2013 Q2
Cliff Asness's AstraZeneca PLC (AZN) Holding Value Over Time
Track share changes against reported price movement
Quarterly AstraZeneca PLC (AZN) Trades by Cliff Asness
| Period | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q2 2014 | +2.37 M | New Buy | 2.37 M | $37.16 |
| Q3 2014 | -2.37 M | Sold Out | 2.37 M | $0.00 |
| Q3 2023 | +4,740 | New Buy | 4,740 | $67.72 |
| Q4 2023 | +363 | Add 7.66% | 5,103 | $67.35 |
| Q1 2024 | +1,341 | Add 26.28% | 6,444 | $67.75 |
| Q2 2024 | +7,241 | Add 112.37% | 13,685 | $77.99 |
| Q3 2024 | +5,179 | Add 37.84% | 18,864 | $77.91 |
| Q4 2024 | +6,947 | Add 36.83% | 25,811 | $65.52 |
| Q1 2025 | +11,690 | Add 45.29% | 37,501 | $73.50 |
| Q2 2025 | +16,443 | Add 43.85% | 53,944 | $69.88 |
| Q3 2025 | +30,840 | Add 57.17% | 84,784 | $76.72 |
Cliff Asness's AstraZeneca PLC Investment FAQs
Cliff Asness first purchased AstraZeneca PLC (AZN) in Q2 2014, acquiring 2,372,836 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Cliff Asness has held AstraZeneca PLC (AZN) for 46 quarters since Q2 2014. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Cliff Asness's largest addition to AstraZeneca PLC (AZN) was in Q2 2014, adding 2,372,836 shares worth $88.16 M. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
According to the latest 13F filing for Q3 2025, Cliff Asness's firm, Aqr Capital Management LLC, owns 84,784 shares of AstraZeneca PLC (AZN), valued at approximately $6.5 M. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
As of the Q3 2025 filing, AstraZeneca PLC (AZN) represents approximately 0.00% of Cliff Asness's publicly disclosed stock portfolio, making it one of their key holdings. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Cliff Asness's peak holding in AstraZeneca PLC (AZN) was 2,372,836 shares, as reported at the end of Q2 2014. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.